A Study Of PF-06647263 In Patients With Advanced Solid Tumors

Clinical trial NCT02078752 · TERMINATED

Trial details

NCT number: NCT02078752
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Triple-Negative Breast Cancer

Start date: 2014-04-09
Primary completion: 2017-05-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.